Nippon India Pharma Fund – Direct Growth

Equity . Sectoral / Thematic
Monthly Amount Invested
Duration
Yr
  • Would Have Become
    --
  • Invested Value
    --
  • Total Gain
    --
  • Returns
    -- per annum
₹ 100 ₹ 5,000 1.07 % 0★ ₹ - 10 Years
Min SIP Min Lumpsum Expense Ratio Rating Fund Size Fund Age
₹ 100 ₹ 5,000 1.07 %
Min SIP Min Lumpsum Expense Ratio
0★ ₹ 1.07 Cr 10 Years
Rating Fund Size Fund Age

Scheme Performance

Returns and Ranks ( as on April 28.2022 )
1 Month1M 1 Year1Y 3 Years3Y 5 Years5Y
Trailing Returns -10.15% 26.89% 18.24% 16.49%
Category Average -5.34% -11.37% 13.44% -

Scheme Allocation

Holding
Sector
Asset
Sun Pharma.Inds.
14.91%
Cipla
8.46%
Dr Reddy's Labs
7.53%
Divi's Lab.
7.47%
Torrent Pharma.
6.48%
Others
55.15%
Healthcare Services
17.18%
Debt
1.21%
Cash & Others
-0.21%
Others
81.82%
Equity
99.34%
Reverse Repos
0.89%
Cash & Cash Equivalents
0%
Net Curr Ass/Net Receivables
-0.23%

Exit Load & Tax Implication

Exit Load 1% if redeemed or switchd out on or efore completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units.

Advance Ratio

-0.07 0.99 0.58 -0.07
Alpha SD Beta Sharpe

Risk-O-Meter

AMC Contact Details

Nippon India Mutual Fund
AUM:
2,81,440 Cr
Address:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact:
022-68087000/1860260111
Email ID:
customercare@nipponindiaim.in

Frequently Asked Questions

The NAV of Nippon India Pharma Fund – Direct Growth is ₹302.46 as of 10 August 2022.